デフォルト表紙
市場調査レポート
商品コード
1008269

中国のアミノ酸化合物市場に関する調査報告書(2021年~2025年)

Investigation Report on Chinese Compound Amino Acid Market 2021-2025

出版日: | 発行: China Research and Intelligence | ページ情報: 英文 50 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
中国のアミノ酸化合物市場に関する調査報告書(2021年~2025年)
出版日: 2021年05月28日
発行: China Research and Intelligence
ページ情報: 英文 50 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中国市場でのアミノ酸化合物の売上高は、2016年から2020年まで間、ゆっくりとした成長を維持し、約1.8%のCAGRで成長しました。主な理由には、アミノ酸化合物の臨床需要が比較的安定していることが挙げられます。

2021年から2025年の間におけるアミノ酸化合物カテゴリーの開発に伴い、適応症の数が増加し、売上高と販売量が成長する可能性があると予測されています。また、中国のアミノ酸化合物市場に新規メーカーが加わったことにより、市場競争はますます激しくなり、価格の下落に伴い売上高は増加する見通しです。

当レポートは、中国のアミノ酸化合物市場について調査しており、市場規模や予測、動向、COVID-19による影響、価格、成長要因や機会、脅威、課題、市場シェアなどの情報を提供しています。

目次

第1章 アミノ酸化合物の関連概念

  • アミノ酸化合物の適応症
  • 中国におけるアミノ酸化合物の開発
  • 中国におけるアミノ酸化合物の政府承認
  • 中国でのアミノ酸化合物販売に対するCOVID-19の影響

第2章 中国でのアミノ酸化合物の販売(2016-2020)

  • アミノ酸化合物の売上高
    • 全体的な売上高
    • 地域別の売上高
  • アミノ酸化合物の販売量
    • 全体の販売量
    • 地域別販売量
  • 中国における剤形別アミノ酸化合物の販売(2016-2020)
    • 注射
    • 顆粒
    • カプセル

第3章 中国の主要アミノ酸化合物メーカーの分析(2020)

  • 主要アミノ酸化合物メーカーの市場シェアの分析
    • 売上高別市場シェア調査
    • 販売量別市場シェア調査
  • Guangdong Litai Pharmaceutical Co., Ltd.
    • 企業プロファイル
    • Sailuoan(Guangdong Litai Pharmaceutical Co., Ltd.のアミノ酸化合物)の中国での販売
  • Guanzhou Green Cross Pharmaceutical Co.,Ltd.
    • 企業プロファイル
    • Lvzhian(Guanzhou Green Cross Pharmaceutical Co.,Ltd.のアミノ酸化合物)の中国での販売
  • Hubei Yibantian Pharmaceutical Co.,Ltd.
    • 企業プロファイル
    • Jimin(Hubei Yibantian Pharmaceutical Co.,Ltd.のアミノ酸化合物)の中国での販売
  • Fujian Tianquan Pharmaceutical Co.,Ltd.
    • 企業プロファイル
    • Tianquanlexin(Fujian Tianquan Pharmaceutical Co.,Ltd.のアミノ酸化合物)の中国での販売
  • Liaoning Haisco Pharmaceutical Co.,Ltd.
    • 企業プロファイル
    • Jiesu(Liaoning Haisco Pharmaceutical Co.,Ltd.のアミノ酸化合物)の中国での販売

第4章 中国の各メーカーのアミノ酸化合物の価格(2020-2021)

  • Guangdong Litai Pharmaceutical Co., Ltd. (Sailuoan)
  • Guanzhou Green Cross Pharmaceutical Co.,Ltd. (Lvzhian)
  • Hubei Yibantian Pharmaceutical Co.,Ltd. (Jimin)
  • Fujian Tianquan Pharmaceutical Co.,Ltd. (Tianquanlexin)
  • Liaoning Haisco Pharmaceutical Co.,Ltd. (Jiesu)

第5章 中国のアミノ酸化合物市場の見通し(2021-2025)

  • 中国のアミノ酸化合物市場開発の影響力のある要因
    • 中国のアミノ酸化合物市場に対するCOVID-19の影響
    • 市場の成長要因と機会
    • 市場の脅威と課題
  • 市場規模の予測
  • 市場動向の予測
図表

List of Charts

  • Chart Patent Information About Compound Amino Acid Injection Registration in China
  • Chart Patent Information About Compound Amino Acid Granules Registration in China
  • Chart Patent Information About Compound Amino Acid Capsules Registration in China
  • Chart Sales Value of Compound Amino Acid Injection over the World
  • Chart Sales Value of Compound Amino Acid Granules over the World
  • Chart Sales Value of Compound Amino Acid Capsules over the World
  • Chart Sales Value of Compound Amino Acid Injection in China, 2016-2020
  • Chart Sales Value of Compound Amino Acid Granules in China, 2016-2020
  • Chart Sales Value of Compound Amino Acid Capsules in China, 2016-2020
  • Chart Sales Value of Compound Amino Acid Injection in China by Regions, 2016-2020
  • Chart Sales Value of Compound Amino Acid Granules in China by Regions, 2016-2020
  • Chart Sales Value of Compound Amino Acid Capsules in China by Regions, 2016-2020
  • Chart Sales Volume of Compound Amino Acid Injection in China, 2016-2020
  • Chart Sales Volume of Compound Amino Acid Granules in China, 2016-2020
  • Chart Sales Volume of Compound Amino Acid Capsules in China, 2016-2020
  • Chart Sales Volume of Compound Amino Acid Injection in China by Regions, 2016-2020
  • Chart Sales Volume of Compound Amino Acid Granules in China by Regions, 2016-2020
  • Chart Sales Volume of Compound Amino Acid Capsules in China by Regions, 2016-2020
  • Chart Market Share by Sales Value of Top Compound Amino Acid Injection Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Compound Amino Acid Granules Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Compound Amino Acid Capsules Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of Sailuoan in China, 2016-2020
  • Chart Sales Value and Volume of Lvzhian in China, 2016-2020
  • Chart Sales Value and Volume of Jimin in China, 2016-2020
  • Chart Sales Value and Volume of Tianquanlexin in China, 2016-2020
  • Chart Sales Value and Volume of Jiesu in China, 2016-2020
  • Chart Referential Prices of Sailuoan in China by Regions, 2020-2021
  • Chart Referential Prices of Lvzhian in China by Regions, 2020-2021
  • Chart Referential Prices of Jimin in China by Regions, 2020-2021
  • Chart Referential Prices of Tianquanlexin in China by Regions, 2020-2021
  • Chart Referential Prices of Jiesu in China by Regions, 2020-2021
  • Chart Forecast on Sales Value of Compound Amino Acid Injection in China, 2021-2025
  • Chart Forecast on Sales Value of Compound Amino Acid Granules in China, 2021-2025
  • Chart Forecast on Sales Value of Compound Amino Acid Capsules in China, 2021-2025
  • Chart Forecast on Sales Volume of Compound Amino Acid Injection in China, 2021-2025
  • Chart Forecast on Sales Volume of Compound Amino Acid Granules in China, 2021-2025
  • Chart Forecast on Sales Volume of Compound Amino Acid Capsules in China, 2021-2025
目次
Product Code: 2105504

Compound Amino Acid is clinically used for patients with insufficient protein intake, malabsorption, and other amino acids that cannot meet the requirements of body metabolism. It was developed by Japan Ajinomoto Pharmaceutical Co., Ltd. At present, more than 20 categories of Compound Amino Acid injections have been approved in China. By 2020, in addition to Guangdong Litai Pharmaceutical Co., Ltd. in the Chinese Compound Amino Acid market, there are 34 companies, such as Guangzhou Green Cross Pharmaceutical Co., Ltd., Hubei Bantian Pharmaceutical Co., Ltd., Fujian Tianquan Pharmaceutical Co., Ltd., and Liaoning Haisco Pharmaceutical Co., Ltd.

According to CRI analysis, the sales of Compound Amino Acids in the Chinese market have basically maintained a slow growth from 2016 to 2020, reaching about 1.53 billion in 2020, and the CAGR from 2016 to 2020 is about 1.8%. The main reason is that the clinical demand for Compound Amino acids is relatively stable.

CRI predicts that with the development of Compound Amino Acid categories from 2021 to 2025, the number of indications will increase so that sales and sales volume have potential for growth. Moreover, with the addition of new manufacturers in the Chinese Compound Amino Acid market, market competition will become increasingly fierce and sales will increase as prices fall.

Topics Covered:

  • The impact of COVID-19 on China's Compound Amino Acid market
  • Sales value of China's Compound Amino Acid 2016-2020
  • Competitive landscape of China's Compound Amino Acid market
  • Prices of Compound Amino Acid in China
  • Prices of Compound Amino Acid in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Compound Amino Acid market
  • Prospect of China's Compound Amino Acid market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Compound Amino Acid

  • 1.1 Indications for Compound Amino Acid
  • 1.2 Development of Compound Amino Acid in China
  • 1.3 Governmental Approval of Compound Amino Acid in China
  • 1.4 The Impact of COVID-19 on Compound Amino Acid sales in China

2 Sales of Compound Amino Acid in China, 2016-2020

  • 2.1 Sales Value of Compound Amino Acid
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Regions
  • 2.2 Sales Volume of Compound Amino Acid
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Regions
  • 2.3 Sales of Compound Amino Acid by Dosage Form in China, 2016-2020
    • 2.3.1 Injection
    • 2.3.2 Granules
    • 2.3.3 Capsules

3 Analysis of Major Compound Amino Acid Manufacturers in China In 2020

  • 3.1 Analysis of Market Share of Major Compound Amino Acid Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Guangdong Litai Pharmaceutical Co., Ltd.
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Sailuoan (Guangdong Litai Pharmaceutical Co., Ltd.'s Compound Amino Acid) in China
  • 3.3 Guanzhou Green Cross Pharmaceutical Co.,Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Lvzhian (Guanzhou Green Cross Pharmaceutical Co.,Ltd.'s Compound Amino Acid) in China
  • 3.4 Hubei Yibantian Pharmaceutical Co.,Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Jimin (Hubei Yibantian Pharmaceutical Co.,Ltd.'s Compound Amino Acid) in China
  • 3.5 Fujian Tianquan Pharmaceutical Co.,Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of Tianquanlexin (Fujian Tianquan Pharmaceutical Co.,Ltd.'s Compound Amino Acid) in China
  • 3.6 Liaoning Haisco Pharmaceutical Co.,Ltd.
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of Jiesu (Liaoning Haisco Pharmaceutical Co.,Ltd.'s Compound Amino Acid) in China

4 Prices of Compound Amino Acid for Different Manufacturers in China, 2020-2021

  • 4.1 Guangdong Litai Pharmaceutical Co., Ltd. (Sailuoan)
  • 4.2 Guanzhou Green Cross Pharmaceutical Co.,Ltd. (Lvzhian)
  • 4.3 Hubei Yibantian Pharmaceutical Co.,Ltd. (Jimin)
  • 4.4 Fujian Tianquan Pharmaceutical Co.,Ltd. (Tianquanlexin)
  • 4.5 Liaoning Haisco Pharmaceutical Co.,Ltd. (Jiesu)

5 Prospect of Chinese Compound Amino Acid Market, 2021-2025

  • 5.1 Influential Factors of Chinese Compound Amino Acid Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Compound Amino Acid Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend